Podcasts Health & Fitness Medicine The Curbsiders Internal Medicine Podcast #44: Obesity Medication Overview from AACE 2017

#44: Obesity Medication Overview from AACE 2017

Published: June 19, 2017, 7 a.m.

Master the safe and effective use of\xa0obesity medications with Endocrinologist, Dr. Karl Nadolsky (co-author of 2016 AACE Obesity guidelines), Director of the Diabetes, Obesity & Metabolic Institute at Walter Reed National Military Medical Center. We get under the hood of each FDA approved obesity medication plus some of our normal hijinks. Check out episode #23 for a more general overview of obesity.

\n

Full show notes available at http://thecurbsiders.com/podcast

\n

Join our newsletter mailing list. Rate us on iTunes, recommend a guest or topic and give feedback at thecurbsiders@gmail.com.

\n

Time Stamps

\n

00:00 Intro

\n

03:12 Picks of the week

\n

08:44 Rapid fire questions

\n

13:00 Counsel patients about obesity

\n

14:40 Pathophysiology of obesity

\n

18:00 Case

\n

22:46 Phentermine/topiramate (Qsymia)

\n

26:20 Bupropion/naltrexone (Contrave)

\n

29:18 Liraglutide (Saxenda)

\n

34:32 Orlistat (Alli, Xenical)

\n

37:35 Cost issues

\n

40:18 Lifelong medical therapy for obesity

\n

42:44 Dr. Nadolsky\u2019s take home points

\n

44:45 The Curbsiders recap and discuss their experience with obesity medications

\n

52:28 Outro

\n

Tags: assistant, care, doctor, education family, foam, foamed, health, hospitalist, hospital, internal, internist, nurse, medicine, medical, physician, practitioner, primary, resident, student, obesity, pharmacotherapy, weight loss, safety, side effects, orlistat, alli, naltrexone, bupropion, contrave, phentermine, topiramate, qsymia, lorcaserin, belviq, FDA